Medidata announced that Medpace Inc. has entered into an agreement to integrate Medidata Rave Imaging with Medpace's imaging systems and workflow. This will create a seamless platform for capturing, managing, analyzing and storing images and imaging data for clinical trials. Medpace is a leading contract research organization (CRO) with a wholly-owned and fully integrated imaging core lab that offers a suite of global imaging services to enhance and expedite biopharmaceutical and medical device development.

Using Medidata Rave Imaging, Medpace's imaging core lab will: Provide Medpace customers with a single, familiar location for site data entry and image uploads; Optimize resources and workflow, reduce manual reconciliation steps, increase data visibility, and create a single data repository on a unified trial platform; Compute quantitative imaging biomarkers for clinical trials in oncology, metabolic disease, and neuroscience; Create an integrated workflow to determine patient eligibility, monitor disease progression or response, and make go /no go clinical decisions that provide customers with a more streamlined and effective approach for managing vital imaging components of their study.